BSEInsider Trading / SAST4 Nov 2026 · 4 Nov 2026, 03:31 pm

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2026 for V C Nannapaneni

Natco Pharma Ltd · 524816

✦ AI SummaryPledge

Natco Pharma Ltd's promoter V.C. Nannapaneni has created a pledge of 8,50,000 equity shares for the purpose of subscribing to the company's Rights Issue.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Attachments (1)

📄

88C2E5B0_B529_4CA2_B16B_549E6D26D8D7_153110.PDF.pdf

pdf

Download →
View document text
4th November, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai 400 001 Maharashtra, India Scrip Code: 524816 Dear Sir/Madam, Sub:- Disclosure under Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Ref: Earlier disclosure dated 12th October, 2026 and email received from BSE dated 3rd November, 2026 With reference to the above cited subject, I, V.C. Nannapaneni, Promoter of the Company hereby disclose that I have created pledge of 8,50,000 equity shares of Rs.2/-each of the Company for the purpose of subscribing to the Rights Issue of the Company. In this regard the, the revised disclosure is enclosed with this letter. I request to kindly take note of the same. Thanking you Yours faithfully "<--~k::s:--,-<e:s~ V.C. Nannapaneni Promoter Encl. as above Format for disclosure by the Promoter(s) to the stock exchanges and to the Target Company for encumbrance of shares / invocation of encumbrance/ release of encumbrance, in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) Natco Pharma Limited Names of the Stock Exchanges where the shares of the target company are listed National Stock Exchange of India Limited and BSE Limited Date of reporting 12-10-2026 Name of the promoter or PAC on whose shares encumbrance has been V. C. Nannapaneni created/releasedfin'iioked Details of the creation/iF1veeatieF1ffelease of encumbrance: Name of Promoter holding in Promoter holding Details of events pertaining to encumbrance (3) Post event the the already holding of promoter target company (1) encumbered (2) encumbered (s) or shares PACs {creation with [(2)+(3)] I him* release [(2)-(3)] I invocation Number %of Number % of Type of Date of Type of Reasons for Number %of Name of No. of %of total total event creation/ encumbrance Encumbrance** share the entity shares total share share (creation inv'oeation (pledge/ lien/ capit in whose share capital capital / rete-ase retea-seof non disposal al favor capit f encumbrance undertaking/0th shares al invoeatio ers) encumber fl) ed*** V. C. Nannapaneni 2,80,45,905 15.66 Nil Nil Creation 09-10-2026 Pledge Pledge was created 8,50,000 0.47% Bajaj 8,50,000 0.47% of pledge for the purpose of Financial subscribing to the Securities Rights Issue of the Limited Company --= ~ fv:::::- ,a· ~ Signature of the Authorized Signatory: V.C. Nannapaneni Place: Hyderabad Date: 12-10-2026 *The names of all the promoters, their shareholding in the target company and their pledged shareholding as on the reporting date should appear in the table irrespective of whether they are reporting on the date of event or not. ** For example, for the purpose of collateral for loans taken by the company, personal borrowing, third party pledge, etc. ***This would include name of both the lender and the trustee who may hold shares directly or on behalf of the lender.